|
|
Volumn 98, Issue 1, 2006, Pages 9-11
|
|
Is nanotechnology ready for primetime?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DENDRIMER;
DOCETAXEL;
LIPOSOME;
NANOPARTICLE;
PACLITAXEL;
SUNSCREEN;
BREAST CANCER;
CANCER DIAGNOSIS;
CANCER RESEARCH;
CLINICAL PRACTICE;
CONTROLLED DRUG RELEASE;
DRUG DELIVERY SYSTEM;
DRUG HALF LIFE;
DRUG INDUSTRY;
DRUG SAFETY;
DRUG TARGETING;
ENVIRONMENTAL MONITORING;
GENE THERAPY;
GOVERNMENT;
HEALTH CARE FINANCING;
HUMAN;
MARINE ENVIRONMENT;
MEDICAL RESEARCH;
NANOTECHNOLOGY;
NONHUMAN;
NOTE;
OXIDATIVE STRESS;
PARTICLE SIZE;
PHARMACEUTICAL ENGINEERING;
PRIORITY JOURNAL;
TOXICITY TESTING;
ANIMALS;
ANTINEOPLASTIC AGENTS;
DENDRIMERS;
DRUG CARRIERS;
HUMANS;
NANOMEDICINE;
NANOSTRUCTURES;
NANOTECHNOLOGY;
NATIONAL INSTITUTES OF HEALTH (U.S.);
NEOPLASMS;
RESEARCH SUPPORT;
UNITED STATES;
|
|
EID: 30344445685
PISSN: 00278874
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/djj028 Document Type: Note |
|
Times cited : (29)
|
|
References (0)
|